Press release
Emerging Trends to Reshape the Controlled Release Drug Delivery Market: Groundbreaking Microparticle Technology Revolutionizing Controlled-Release Drug Delivery as a Key Influencer
Controlled Release Drug Delivery
Controlled Release Drug Delivery Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Rapid expansions have been observed in the market size of controlled release drug delivery in recent years. The market is forecasted to swell from $65.44 billion in 2024 to $73.01 billion in 2025, boasting a formidable compound annual growth rate (CAGR) of 11.6%. Factors contributing to this historic growth include the development of innovative drug delivery systems, initial polymer-based formulations, introduction of microencapsulation methods, the advent of transdermal delivery, regulatory approvals, and standardization.
Controlled Release Drug Delivery Market Size Forecast: What's the Projected Valuation by 2029?
The controlled release drug delivery market is predicted to rapidly expand in upcoming years, swelling to a valuation of $119.41 billion by 2029 with an impressive compound annual growth rate (CAGR) of 13.1%. Factors stimulating this growth within the predicted timeline include a shift towards personalized medicine, patient-centric technological enhancements, broadening of biologics and biosimilars fields, market growth in emerging regions and advancements in polymer science. The major trends for the forecast period are centered around biodegradable and biocompatible materials, nanotechnology evolution, personalized and targeted treatments, progress in implantable devices technology, and novel encapsulation methods.
View the full report here:
https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report
What Are the Drivers Transforming the Controlled Release Drug Delivery Market?
The increasing occurrence of chronic illnesses is anticipated to boost the controlled release drug delivery market's expansion. These long-term diseases, also referred to as noncommunicable ailments, include conditions like heart disease, cancer, and diabetes, which last longer than a year and necessitate ongoing medical attention and often limit daily activities. The role of controlled-release drug delivery in treating these chronic diseases is significant. This is particularly relevant for patients with long-term diseases requiring prolonged treatment, or for those living in regions with limited resources and healthcare accessibility, as medications providing extended release are crucial. As per a report published by the World Health Organization (WHO), a health-focused agency based in Switzerland in September 2022, some 41 million individuals die every year due to chronic diseases, accounting for 74% of all global fatalities. Additionally, chronic illnesses claim the lives of 17 million people before they turn 70. Furthermore, 77% of chronic disease-related deaths happen in low to middle-income countries. These figures are projected to increase, hence, the escalating frequency of chronic diseases is stimulating the controlled release drug delivery market's growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp
What Long-Term Trends Will Define the Future of the Controlled Release Drug Delivery Market?
The controlled-release drug delivery market is seeing a surge in technological innovations, which is one prominent trend. The established businesses in this market are focusing on adopting new technologies to retain their market position. For instance, Evonik Industries AG, a pharmaceutical company from Germany, introduced UDRATEC SoluFlow in March 2022. This innovation features a unique microparticle technology designed to enhance the solubility of active components in oral medications. This emulsion-based technology surpasses solubility limits that conventional production techniques fall short of. UDRATEC SoluFlow expands Evonik Health Care's portfolio of oral drug delivery solutions, inclusive of oral excipients like EUDRAGIT functional polymers, ready-to-fill caps like EUDRACAPTM, and various other technologies and services that enhance medication efficiency.
Which Segments in the Controlled Release Drug Delivery Market Offer the Most Profit Potential?
The controlled release drug delivery market covered in this report is segmented -
1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Personal, Research, Other End Users
Subsegments:
1) By Wurster Technique: Spray Coating, Fluid Bed Coating
2) By Coacervation: Simple Coacervation, Complex Coacervation
3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation
4) By Implants: Biodegradable Implants, Non-Biodegradable Implants
5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems
6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes
7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp
Which Firms Dominate the Controlled Release Drug Delivery Market by Market Share and Revenue in 2025?
Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.
Which Regions Offer the Highest Growth Potential in the Controlled Release Drug Delivery Market?
North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Trends to Reshape the Controlled Release Drug Delivery Market: Groundbreaking Microparticle Technology Revolutionizing Controlled-Release Drug Delivery as a Key Influencer here
News-ID: 4088362 • Views: …
More Releases from The Business Research Company
Smart Pill Dispenser Market Analysis Highlights Growth To $5.54 Billion By 2030 …
The smart pill dispenser market is gaining significant momentum with promising growth prospects expected over the coming years. This expanding sector is being shaped by technological advancements and increasing demand for efficient medication management solutions, particularly as healthcare delivery continues to evolve toward remote and connected care models. Let's explore the market's projected growth, key players, emerging trends, and detailed segmentation.
Forecasted Growth and Market Value of the Smart Pill Dispenser…
Smart Orthopedic Implants Market Report 2026 Market Outlook Supported By A Forec …
The smart orthopedic implants market is set to experience substantial growth as technological advancements and demographic shifts drive demand. Innovations in sensor technology and artificial intelligence are transforming orthopedic care, offering more personalized and effective treatment options. This evolving sector is attracting significant attention from both established players and new entrants aiming to capitalize on emerging opportunities.
Projected Growth Trajectory for the Smart Orthopedic Implants Market Through 2030
The smart…
Smart Mattress Overlay (Hospital) Market Outlook Highlights Strategic Opportunit …
The smart mattress overlay (hospital) market is set to undergo significant expansion in the coming years, driven by advancements in healthcare technology and increasing demand for improved patient care solutions. This market is poised to transform hospital infrastructure and patient management by integrating intelligent systems designed for enhanced monitoring and comfort. Let's explore the market's size, key players, trends, and segmentation to understand its future trajectory.
Market Size Outlook and Growth…
Smart Infusion Pumps Market Research Reveals Strong 9.2% CAGR Outlook Through 20 …
The smart infusion pumps market is on the brink of significant expansion driven by ongoing technological advancements and growing healthcare demands. As healthcare providers seek safer and more efficient drug delivery solutions, smart infusion pumps are becoming increasingly vital. Let's explore the market size, key players, emerging trends, and major segments shaping this industry's future.
Projected Growth and Market Size of the Smart Infusion Pumps Market
The smart infusion pumps…
More Releases for Delivery
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Last Mile Delivery: Your Fast Track to Delivery Efficiency
The importance of last-mile logistics has increased significantly in recent years due to the rapid growth of e-commerce, evolving consumer demands, and the necessity for efficient and timely deliveries. Covid-19 has also played a part in hastening the rise of last-mile deliveries. In logistics, 'first-mile' and 'last-mile' delivery are terms used to describe the movement of goods within the supply chain. The first leg of the supply chain journey commences…
Smart Drug Delivery Systems Market: Revolutionizing Healthcare Delivery
In a rapidly evolving landscape of healthcare, smart drug delivery systems (SDDS) have emerged as a transformative force, catering to the increasing demand for advanced treatment solutions. According to a recent report, the global smart drug delivery systems market was valued at a staggering US$ 8.7 billion in 2022, with projections indicating a remarkable CAGR of 15.2% from 2022 to 2031. By the end of this forecast period, the market…
Revolutionizing Last-Mile Delivery: The Growing Delivery Robots Market
"According to the research report, the global delivery robots market was valued at USD 148.07 million in 2022 and is expected to reach USD 2,148.92 million by 2032, to grow at a CAGR of 30.7% during the forecast period."
Polaris Market Research has recently published the latest update on Delivery Robots Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis, encompassing its…
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of…
